Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67.
Prostate. 2024 Apr 17. doi: 10.1002/pros.24710. Online ahead of print.
Prostate. 2024.
PMID: 38629249
Molecular complexity of intraductal carcinoma of the prostate.
Zhu S, Xu N, Zeng H.
Zhu S, et al.
Cancer Med. 2024 Jan;13(2):e6939. doi: 10.1002/cam4.6939.
Cancer Med. 2024.
PMID: 38379333
Free PMC article.
Review.
Item in Clipboard
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.
Zhao J, Xu N, Zhu S, Nie L, Zhang M, Zheng L, Cai D, Sun X, Chen J, Dai J, Ni Y, Wang Z, Zhang X, Liang J, Chen Y, Hu X, Pan X, Yin X, Liu H, Zhao F, Zhang B, Chen H, Miao J, Qin C, Zhao X, Yao J, Liu Z, Liao B, Wei Q, Li X, Liu J, Gao AC, Huang H, Shen P, Chen N, Zeng H, Sun G.
Zhao J, et al.
Cancer Res. 2024 Jan 2;84(1):154-167. doi: 10.1158/0008-5472.CAN-23-1176.
Cancer Res. 2024.
PMID: 37847513
Item in Clipboard
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.
Xu N, Zhao J, Zhao F, Liu H, Yin W, Zhu S, Nie L, Sun G, Zheng L, Liu Z, Cai D, Chen J, Dai J, Ni Y, Wang Z, Zhang X, Liang J, Chen Y, Hu X, Pan X, Yin X, Zhu X, Zhang Y, Wang Z, Zeng Y, Wang M, Shen P, Chen N, Zeng H.
Xu N, et al.
J Cancer Res Clin Oncol. 2023 Aug;149(10):7247-7258. doi: 10.1007/s00432-023-04639-9. Epub 2023 Mar 13.
J Cancer Res Clin Oncol. 2023.
PMID: 36907910
Item in Clipboard
Cite
Cite